Thought post up quick chart then an end Aug article around the processing of De Novos (times etc) and some formal FDA Report snips plus the full Qtrly Report as at 30.6.19 which gives a drill down into their performances eg. De Novos rec'd, approved, outstanding etc. Just click on the page number in the index straight to req'd page to review.
Will maybe give some more insight into where things are at (or not?). Hopefully of use to holders. GL
RAP Price at posting:
20.0¢ Sentiment: None Disclosure: Not Held